Gland Pharma Ltd
Gland Pharma's GHG Emissions Data Preview
In 2024, Gland Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Gland Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Gland Pharma's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Gland Pharma amounted to 96,890 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Gland Pharma increased by 4.63%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Gland Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Gland Pharma's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Gland Pharma were 15,736 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Compared to the previous year (2023), Gland Pharma's Scope 1 emissions increased by 31.91%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Gland Pharma's Scope 2 emissions?
In 2024, Gland Pharma reported Scope 2 greenhouse gas (GHG) emissions of 81,154 tCOâ‚‚e without specifying the calculation method.
Has Gland Pharma reduced its Scope 2 emissions over time?
Compared to the previous year (2023), Gland Pharma's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Gland Pharma 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does Gland Pharma use for Scope 2 reporting?
In 2024, Gland Pharma reported its Scope 2 emissions using an unspecified methodology.
Gland Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)